glp-1 receptor agonists blindness risk Safety and Tolerability of Glucagon-Like Peptide-1 Agonists: A State-of-the-Art Narrative Review | Drugs Research shows GLP-1 drugs safeguard
Description
He W, Yu S, Wang L, He M, Cao X, Li Y, et al
Available from: www.dtu.ox.ac.uk/tecos [accessed 3 April 2011]
10.3109/15622970802573246 [DOI] [PubMed] [Google Scholar] Porter W
[DOI] [PubMed] [Google Scholar] 2.Astrup A, Rossner S, Van Gaal L, et al
Slowing Gastric Emptying GLP-1 RAs inhibit gastric motility, delaying the passage of food from the stomach to the small intestine
